Artiva Biotherapeutics, Inc. ARTV
- AB-201 — Breast Cancer
- AB-201 — Gastric Cancer
- AB-201 — Bladder Cancer
HER2 (8 companies · 13 programs)
Companies with an active program directed at HER2.
Vir Biotechnology, Inc. VIR
- VIR-5818 — Breast Cancer Phase 1
- VIR-5818 — Colorectal Cancer Phase 1
- VIR-5818 Phase 1
Zymeworks Inc. ZYME
- Ziihera — Biliary Tract Cancer Approved
- Ziihera — Gastroesophageal Adenocarcinoma Approved
Absci Corporation ABSI
- ABS-501 Preclinical
Adagene Inc. ADAG
- ADG138 — Advanced Solid Tumors Preclinical
Cogent Biosciences, Inc. COGT
- CGT4255 — Advanced Solid Tumors Phase 1
FATE THERAPEUTICS INC FATE
- FT825 — Solid Tumors Phase 1
Oric Pharmaceuticals, Inc. ORIC
- enozertinib — Non-Small Cell Lung Cancer Phase 1